Sign in

NCT07621783Recruiting

Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context

Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context: LEADER Trial.

Source: ClinicalTrials.gov · Last updated 2 Jun 2026

Brief summary (registry, in English)

Prospectively study the correlation between Leucine-rich α2-glycoprotein (LRG) and clinical/endoscopic/histological disease activity in patients with inflammatory bowel disease (IBD) in Europe.

Status (registry)
Recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
24 May 2026
Start date
1 May 2026
Primary completion date
31 Dec 2026
Lead sponsor
Imelda GI Clinical Research Center
NCT number
NCT07621783

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 1 May 2026 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient with IBD unspecified
  • Patient with ileo- or colostomy
  • Patient with total colectomy
  • Women that are pregnant

Who the study is looking for

  • ≥18 years
  • Patient with confirmed diagnosis of IBD
  • Patient with planned endoscopy (ileocolonoscopy for Crohn's disease (CD)/ulcerative colitis (UC) or sigmoidoscopy for UC) for the assessment of endoscopic disease activity according to routine practice
  • willing to provide informed consent

Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Imelda General Hospital
Coordinator of this site? Confirm its status
BonheidenBelgiumRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.